Controlling the ingress of contamination particles into cleanrooms and other controlled environments is critical to maintaining product and process integrity. LABTECH Solution pass boxes and transfer hatches are an effective solution because they allow materials to be transferred into the controlled environment without actual movement of personal .They can also be used to protect the external environment from the output of contamination.

Fabtech’s Dynamic Passbox is a GMP compliant system is used to transfer materials between classified areas. It has a re-circulatory air system with a certain percentage of air intake as fresh air to keep it under positive pressure. The material airlock serves as a barrier between greyroom and cleanroom It has a microprocessor-based controller to manage door interlock, UV light–hour metre, door open delay and other application based requirements. Validation is per IEST RP with air flow visualisation and specific execution based on application.

Advanced Pelletized Nutraceuticals by WBCIL WBCIL’s pellets are advanced, multi-particulate dosage forms developed using precision pelletization technology. This ensures uniform particle size, excellent flow properties, and reliable dissolution performance. These pellets support immediate, sustained, controlled, and delayed-release formulations, offering high bioavailability, consistent drug release, and improved patient compliance. Key Benefits of WBCIL’s Pellet Technology: • Sustained Release Control: Active ingredients are released gradually over time. • Dose Flexibility & Uniformity: Suitable for capsules, tablets, oral suspensions, etc. • GI Safety & Reduced Irritation: Minimizes local high concentrations, ideal for acid-sensitive APIs. • Targeted Delivery: Can be engineered for site-specific drug delivery in the GI tract. • Improved Patient Compliance: Small size, taste-masked, and dosing intervals of 12-24 hours. Product Offerings: Liposomal Pellets: • Liposomal Iron 7% • Liposomal Calcium 20% • Liposomal Magnesium 15% • Liposomal Vitamin C 35% • Liposomal Zinc 15% • Liposomal Vitamin K2 0.5% • Liposomal Glutathione 35% • Liposomal Alpha Lipoic Acid 50% Newly Developed Pellets: • Aceclofenac 90% • Amlodipine 5% • Aspirin 53% • Cyclobenzaprine HCl 50% • Domperidone 7.5% • Ibuprofen 40% • Pancreatin 80% • Pantoprazole 50% • Simethicone 24% Other Pellets: • Ferrous Ascorbate 7% • Ferrous Bisglycinate 15% • Ferrous Glycine Sulphate 24% • Iron Polymaltose Complex 20% • IPC Blended (with Folic Acid) • Calcium Citrate Malate 20% • L-Methylfolate 1% • Liposomal Methylcobalamin 500 mcg • Sodium Butyrate 90% WBCIL’s liposomal pellets represent a breakthrough in controlled drug release, enhancing protection for sensitive APIs and improving absorption for more effective therapeutic outcomes. We also offer custom development for tailored formulations to meet specific regulatory and release profile requirements.